Disrupting disruption with disruptive disruptions since 2010.
The typical 10-year lifespan of a venture capital fund from raising money to returning capital to LPs, with investment happening in years 1-5 and exits in years 5-10. It's why your VC keeps asking about your exit timeline.
The maximum valuation at which a convertible note or SAFE will convert to equityβa safety net for early investors betting on you when you were nobody. The lower the cap, the more expensive your desperation was.
Past tense of churning, describing customers who've abandoned ship or accounts that have been excessively traded for commissions. In the startup world, it's the past tense of failureβthese are the users who tried your product and decided literally anything else was better. When your investors ask about churned customers, it's never a fun conversation.
The minimum annual return (typically 8%) that limited partners receive before general partners can claim carried interest, functioning as a hurdle rate to ensure LPs get paid first. Think of it as making the GP eat their vegetables before getting dessert.
The formal demand from a general partner to limited partners to wire their committed funds, usually with 10-30 days notice and an implied "or else" hanging in the air. It's how venture funds move committed money from promised to deployed.
The amount of predictable revenue a SaaS company makes yearlyβthe metric that determines whether you're 'growth' or 'dead.'
The AARRR framework measuring Acquisition, Activation, Retention, Referral, and Revenueβthe key metrics for growth-stage startups. Named because AARRR sounds like a pirate, which is somehow still funny to founders.
The initial capital injection used to plant your business idea and hope it doesn't get eaten by birds before it sprouts.
Making investment decisions at lightning speed with minimal diligence, named after Tiger Global's spray-and-pray approach during the 2020-2021 bubble. High velocity, low conviction, maximum FOMO.
An experienced executive or advisor brought into a startup to add operational credibility and grown-up supervision to a young founding team. Think adult daycare, but for unicorn hopefuls.
The overwhelming wave of convertible notes and SAFEs that convert to equity during a priced round, often revealing a far more complex cap table than founders realized. The moment when chickens come home to roost, except the chickens are financial instruments.
When a startup gets stuck endlessly perfecting their product demo instead of actually selling to customers or raising funds. It's the entrepreneurial version of rearranging deck chairs on the Titanic.
Legal promises in investment agreements where founders swear everything they've said is true and the company isn't hiding skeletons. Breaking these can result in personal liability, making due diligence the most stressful time to discover that intern you hired in 2019 never signed an IP assignment.
A venture fund typically under $50M that invests small checks in very early-stage startups. They offer founder-friendly terms and actual attention, mainly because they can't afford fancy offices or ignore their investments.
An IRS-mandated appraisal of your company's common stock price, required so employees don't accidentally commit tax fraud when exercising options. It's always mysteriously lower than what you tell investors your company is worth.
A startup incubator or accelerator where fledgling companies are artificially nurtured in batches, given standardized advice, and released into the wild to either soar or become someone's acqui-hire. Like its fish farm counterpart, success depends on carefully controlled conditions, periodic feeding (of capital), and accepting that most won't make it to maturity. The industrial approach to entrepreneurship for founders who enjoy being treated like salmon.
A schedule requiring founders to earn their equity over time, typically 4 years with a 1-year cliff. The investor-imposed acknowledgment that founding a company doesn't mean you'll stick around to build it.
The magical realm where scientists play God with DNA and investors play roulette with their portfolios. Short for biotechnology, it's the industry that promises to cure cancer, extend your lifespan, and justify obscene R&D budgetsβall while burning through cash faster than a lab incinerator. Whether it's CRISPR gene editing or synthetic biology, biotech is where biology meets business and hope meets hype.
A pejorative term for investors who swoop in during distressed situations to extract maximum value at founders' expense. The same people who call themselves 'value investors' on their websites.
A VC or advisor who has actually built and run companies rather than just invested in them from the sidelines. The startup equivalent of a war veteran versus someone who just played Call of Duty.
When a company or investor offers to buy shares from existing shareholders at a set price, providing liquidity without a full exit. A release valve for the equity pressure cooker.
Also called tag-along rights, these allow minority shareholders to join a sale transaction if majority holders are selling their shares. The 'if you're abandoning ship, I'm coming too' clause.
Excess stock options or debt that will dilute existing shareholders, hanging over the cap table like a financial storm cloud. Future pain that everyone pretends isn't there.
Risky business undertakings or investments that could either make you rich or teach you expensive lessons about market dynamics. In startup speak, it's what venture capitalists fund, hoping that one unicorn will make up for the nine failures. Think of ventures as business experiments where the hypothesis is "this will make money" and the results are usually mixed.